Immunogenicity of pneumococcal vaccination in renal transplant recipients and hemodialysis patients: a comparative controlled trial [0.03%]
肾移植受者和血液透析患者肺炎球菌疫苗免疫原性的对照试验研究
Vahid Pourfarziani,Mohammad Bagher Ramezani,Saeed Taheri et al.
Vahid Pourfarziani et al.
Background: The objectives of this study were: to assess and compare the antibody responses of renal allograft recipients and dialysis patients to pneumococcal vaccination. ...
Comparative Study
Annals of transplantation. 2008;13(3):43-7. DOI: 2008
Mayo risk score for primary biliary cirrhosis: a useful tool for the prediction of course after liver transplantation? [0.03%]
梅奥风险评分在原发性胆汁性肝硬化的预后判断中有何价值？术后移植肝脏的生存状态如何？
Dietmar A Jacob,Marcus Bahra,Sven C Schmidt et al.
Dietmar A Jacob et al.
Background: Survival after orthotopic liver transplantation (OLT) for primary biliary cirrhosis (PBC) is excellent. In order to define the optimal time point for OLT, the Mayo risk score (MRS) was developed and a score of...
Per-operative changes and related factors during simultaneous pancreas-kidney transplantation: first experience at a Brazilian university hospital [0.03%]
巴西一家大学医院同期胰腺-肾脏移植术中改变及其相关因素的首次观察报告
Adriana de Castro Carvalho Faria,Eduardo Costa Teixeira,Felipe Oliveira de Faria et al.
Adriana de Castro Carvalho Faria et al.
Background: Several factors influence ischemic/reperfusion injury in simultaneous pancreas-kidney transplantation (SPKT). Per-operative period is full of intense changes in systemic parameters related to pancreatic reperf...
Ji-ming Sha,Yi-qin Tao,Dao-hang Li et al.
Ji-ming Sha et al.
Background: We have found no study conducted economic issues on patient outcomes after heart transplantation (HTx) in China for further development. Mater...
Laparoscopic live-donor nephrectomy with retroperitoneoscopic access - first case experience [0.03%]
后腹腔镜获取活体供肾术的临床应用
Marcin Słojewski,Tomasz Sluzar,Adam Gołab et al.
Marcin Słojewski et al.
Background: Despite observed huge progress in understanding the immunological basis of transplantation and the development of new immunosuppressive agents that have significantly improved both -- the patient and graft sur...
Case Reports
Annals of transplantation. 2008;13(3):23-6. DOI: 2008
Successful open pulmonary embolectomy for acute massive pulmonary embolism in a recent kidney transplant recipient [0.03%]
肾移植受者的急性大量肺栓塞的开放式肺血栓切除术治疗成功案例报告
Patrick P McHugh,Thomas D Johnston,Roberto Gedaly et al.
Patrick P McHugh et al.
Background: Patients with acute massive pulmonary embolus have a high mortality even with treatment. For patients in whom thrombolytic intervention is contraindicated, surgical pulmonary embolectomy is a viable option. ...
Case Reports
Annals of transplantation. 2008;13(3):19-22. DOI: 2008
Influence of interactions between immunosuppressive drugs on therapeutic drug monitoring [0.03%]
免疫抑制药物之间的相互作用对治疗药物监测的影响
Dirk R Kuypers
Dirk R Kuypers
With the emergence of more immunosuppressive drug combinations in transplantation, the number and complexity of drug interactions have increased and constitute a growing challenge for clinicians. Especially, clinically relevant immunosuppre...
Review
Annals of transplantation. 2008;13(3):11-8. DOI: 2008
Klemens Budde,Petra Glander
Klemens Budde
The combination of synergistic drugs is the main strategy to prevent early acute rejection and to provide long-term effective rejection prophylaxis. Evaluation of drug concentrations to guide drug dosing is routinely established for calcine...
Review
Annals of transplantation. 2008;13(3):5-10. DOI: 2008
The association between cytokine gene polymorphisms and kidney allograft survival [0.03%]
细胞因子基因多态性与肾脏移植存活率的关系研究
Andrzej Pawlik,Leszek Domanski,Jacek Rozanski et al.
Andrzej Pawlik et al.
Background: Cytokines regulate cellular and humoral immune responses. One determinant of the variable cytokine production observed among individuals is genetic polymorphism in cytokine genes. These polymorphisms represent...
Sirolimus induced dyslipidemia in tacrolimus based vs. tacrolimus free immunosuppressive regimens in renal transplant recipients [0.03%]
他克莫司维持的肾移植患者西罗莫司致血脂异常临床特点及其与药物暴露量的关系分析
Hakeam A Hakeam,Ahmed H Al-Jedai,Syed M Raza et al.
Hakeam A Hakeam et al.
Background: Sirolimus is a potent immunosuppressive drug that has been shown to decrease the incidence of rejection post renal transplantation. Dyslipidemia is a well recognized side effect of sirolimus therapy, which may...